A Fixed-Dose Study of Alprazolam 2 mg, Alprazolam 6 mg, and Placebo in Panic Disorder
The DOI matches its Crossref record.
Abstract
A recently reported multinational, 8-week double-blind, placebo-controlled study assessing the efficacy of alprazolam versus placebo in the treatment of panic disorder indicated significant differences favoring alprazolam. We now report the results of a three-site, 6-week, double-blind, fixed-dose study comparing alprazolam 2 mg, alprazolam 6 mg, and placebo in 94 patients with panic disorder with or without agoraphobia. Both alprazolam treatment groups (6 mg and 2 mg) improved significantly more than did the placebo treatment group on most outcome measures. Only a few statistically significant differences between the 6 mg and 2 mg alprazolam groups were discerned, although the pattern of treatment response across measures suggested a dose effect. Dropouts in the placebo group were primarily due to lack of efficacy and in the alprazolam 6 mg group were due to side effects, which may have contributed to the limited differences between groups at study end. The findings suggest that many patients may require less than 6 mg of alprazolam per day for effective treatment of panic disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Mitte, K. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.05.003 · Cited by 396
Minority inclusion in randomized clinical trials of panic disorder
Mendoza, D. B., Williams, M. T., Chapman, L. K., & Powers, M. (2012) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2012.02.011 · Cited by 70
Treatment-Resistant Panic Disorder
Bandelow, B., & Rüther, E. (2004) · CNS Spectrums · doi:10.1017/s1092852900022379 · Cited by 57
Jeejeebhoy, F. M., Dorian, P., & Newman, D. M. (2000) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(99)00103-8 · Cited by 46
Metadata
- Authors
- LYDIARD, R. B., LESSER, I. M., BALLENGER, J. C., RUBIN, R. T., LARAIA, M., & DUPONT, R.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 1992-04
- Volume
- 12
- Issue
- 2
- Pages
- 96???103
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2030881630
- Cited by
- 48
- References
- 0
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Fixed-Dose Study of Alprazolam 2 mg, Alprazolam 6 mg, and Placebo in Panic Disorder. https://app.cochat.ai/papers/10.1097/00004714-199204000-00004
- The paper
- LYDIARD, R. B., LESSER, I. M., BALLENGER, J. C., RUBIN, R. T., LARAIA, M., & DUPONT, R. (1992). A Fixed-Dose Study of Alprazolam 2 mg, Alprazolam 6 mg, and Placebo in Panic Disorder. Journal of Clinical Psychopharmacology. https://doi.org/10.1097/00004714-199204000-00004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.